Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

PHASE3CompletedINTERVENTIONAL
Enrollment

451

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Chronic Insomnia
Interventions
DRUG

Ramelteon

Ramelteon 8 mg, tablets, orally, once daily for up to 42 weeks.

DRUG

Placebo

Ramelteon placebo-matching tablets, orally, once daily for up to 42 weeks.

Trial Locations (48)

Unknown

Birmingham

Hot Springs

Los Angeles

Oakland

San Diego

Santa Monica

Miami

Naples

Winter Park

Atlanta

Overland Park

Louisville

Chevy Chase

Lincoln

New York

Cincinnati

Toledo

Columbia

Austin

Adelaide

Camperdown

Melbourne

Victoria

Brussels

Edegem

České Budějovice

Ostrava-Poruba

Prague

Espoo

Helsinki

Turku

Bron

Clamart

Garches

Paris

Rouffach

Berlin

Göttingen

Hamburg

Münster

Schwalmstadt

Schwerin

Milan

Irkutsk

Moscow

Saint Petersburg

Samara

Yekateringburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY